Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 39 (MTND2P39)
- Target
- MTND2P39
- Molecular classification
- Other (Pseudogene)
01
Overview
MT-ND2 pseudogene 39 (MTND2P39) is classified as a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional gene MT-ND2 but does not encode a protein or possess catalytic or receptor activity[2][5]. Pseudogenes may arise from gene duplication or retrotransposition events and are typically not transcribed or translated into functional proteins. In rare cases, some pseudogenes have regulatory or disease-associated roles, often through non-coding RNA mechanisms, but there are no established biological functions, molecular activities, or therapeutic associations for MTND2P39 at this time[2][5].
- Other names
- MTND2P39mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 39
02
Mechanism of action
Not applicable. There are no drugs targeting this pseudogene.
03
Biological functions
None established; pseudogenes typically lack biological function but may be involved in gene regulation or disease association via non-coding RNA mechanisms. Some mitochondrial pseudogenes have altered expression associated with disease, but this is still under investigation and not definitively characterized for MTND2P39
04
Disease associations
No established direct disease roles. Some other mitochondrial pseudogenes have been reported in differential expression analyses in diseases (e.g., Alzheimer's disease), but specific roles for MTND2P39 are not established and require further study
05
Safety considerations
None reported; no therapeutic interventions or safety issues associated.
06
Interacting drugs
None reported or established.
07
Biomarkers
None reported for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on MT-ND2 pseudogene 39 (MTND2P39).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MT-ND2 pseudogene 39 (MTND2P39).